Reduced expression of 15-lipoxygenase 2 in human head and neck carcinomas

Tumor Biology

Volumn 27, Issue 5, 2006, Pages 261-273

  Wang, Dian ^a   Chen, Shaoying ^a   Feng, Ying ^a   Yang, Qiuhui ^a   Campbell, Bruce H ^a   Tang, Xin ^a   Campbell, William B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

15 Hydroxyeicosatetraenoic acid; 15 Lipoxygenase; Carcinogenesis; Head and neck cancer

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE 2; BIOLOGICAL MARKER; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; GROWTH INHIBITION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM;

EID: 33747508165     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094761     Document Type: Article

References (42)

1. Singh J, Hamid R, Reddy BS: Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer. Cancer Res 1997;57:253-258.
2. Chang WL, Chapkin RS, Lupton JR: Fish oil blocks azoxymethane-induced rat colon tumorigenesis by increasing cell differentiation and apoptosis rather than decreasing cell proliferation. J Nutr 1998;128:491-497.
3. Hubbard NE, Lim D, Erickson KL: Alteration of murine mammary tumorigenesis by dietary enrichment with n-3 fatty acids in fish oil. Cancer Lett 1998;124:1-7.
4. Bull AW, Nigro ND, Golembieski WA, Crissman JD, Marnett LJ: In vivo stimulation of DNA synthesis and induction of ornithine decarboxylase in rat colon by fatty acid hydroperoxides, autoxidation products of unsaturated fatty acids. Cancer Res 1984;44:4924-4928.
5. Setty BN, Dubowy RL, Stuart MJ: Endothelial cell proliferation may be mediated via the production of endogenous lipoxygenase metabolites. Biochem Biophys Res Commun 1987;144:345-351.
6. Glasgow WC, Afshari CA, Barrett JC, Eling TE: Modulation of the epidermal growth factor mitogenic response by metabolites of linoleic and arachidonic acid in Syrian hamster embryo fibroblasts. Differential effects in tumor suppressor gene (+) and (-) phenotypes. J Biol Chem 1992;267:10771-10779.
7. Perkins TM, Shklar G: Delay in hamster buccal mucosa pouch carcinogenesis by aspirin and indomethacin. Oral Surg Oral Med Oral Pathol 1982;53:170-178.
8. Cornwall H, Odukoya O, Shklar G: Oral mucosal tumor inhibition by ibuprofen. J Oral Maxillofac Surg 1983;41:795-800.
9. Panjie WR: Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor. Arch Otolaryngol 1981;107:658-663.
10. Shiotani H, Denda A, Yamamoto K, Kitayama W, Endoh T, Sasaki Y, Tsutsumi N, Sugimura M, Konishi Y: Increased expression of cyclooxygenase-2 protein in 4-nitroquinoline-1-oxide-induced rat tongue carcinomas and chemopreventive efficacy of a specific inhibitor, nimesulide. Cancer Res 2001;61:1451-1456.
11. Thun MJ: NSAID use and decreased risk of gastrointestinal cancers. Gastroenterol Clins N Am 1996;25:333-348.
12. Funkhouser EM, Sharp GB: Aspirin and reduced risk of esophageal carcinoma. Cancer 1995;76:1116-1119.
13. Hwang DH, Fung V, Dannenberg AJ: National Cancer Institute workshop on chemopreventive properties of nonsteroidal anti-inflammatory drugs: role of COX-dependent and -independent mechanisms. Neoplasia 2002;4:91-97.
14. Janne PA, Mayer RJ: Chemoprevention of colorectal cancer. N Engl J Med 2000;342:1960-1968.
15. Piazza GA, Rahm AL, Krutzsch M, Sperl G, Paranka NS, Gross PH, Brendel K, Burt RW, Alberts DS, and Pamukcu R: Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res 1995;55:3110-3116.
16. He TC, Chan TA, Vogelstein B, Kinzler KW: PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 1999; 99:335-345.
17. Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, Lippman SM: 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res 2000;60:6846-6850.
18. Wu J, Xia HH, Tu SP, Fan DM, Lin MC, Kung HF, Lam SK, Wong BC: 15-lipoxygenase-1 mediates cyclooxygenase-2 inhibitor-induced apoptosis in gastric cancer. Carcinogenesis 2003;24:243-247.
19. Shureiqi I, Xu X, Chen D, Lotan R, Morris JS, Fischer SM, Lippman SM: Nonsteroid anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression. Cancer Res 2001;61:4879-4884.
20. Brash AR: Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J Biol Chem 1999;274:23679-23682.
21. Brash AR, Boeglin WE, Chang MS: Discovery of a second 15S-lipoxygenase in humans. Proc Natl Acad Sci USA 1997;94:6148-6152.
22. Shappell SB, Boeglin WE, Olson SJ, Kasper S, Brash AR: 15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinorna. Am J Pathol 1999;155:235-245.
23. Tang S, Bhatia B, Maldonado CJ, Yang P, Newman RA, Liu J, Chandra D, Traag J, Klein RD, Fischer SM, Chopra D, Shen J, Zhau HE, Chung LW, Tang DG: Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells. J Biol Chem 2002;277:16189-16201.
24. Hsi LC, Wilson LC, Eling TE: Opposing effects of 15-lipoxygenase-1 and -2 metabolites on MAPK signaling in prostate. J Biol Chem 2002;277:40549-40556.
25. Xu XC, Shappell SB, Liang Z, Song S, Menter D, Subbarayan V, Iyengar S, Tang DG, Lippman SM: Reduced 15-S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398. Neoplasia 2003;5:121-127.
26. Subbarayan V, Xu XC, Kim J, Yang P, Hoque A, Sabichi AL, Llansa N, Mendoza G, Logothetis CJ, Newman RA, Lippman SM, Menter DG: Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia. Neoplasia 2005;7:280-293.
27. Wang D, Song H, Evans JA, Lang JC, Schuller DE, Weghorst CM: Mutations and down regulation of the transforming growth factor type II receptor gene in primary squamous cell carcinomas of the head and neck. Carcinogenesis 1997;81:2285-2290.
28. Shappell SB, Gupta RA, Manning S, Whitehead R, Boeglin WE, Schneider C, Case T, Price J, Jack GS, Wheeler TM, Matusik RJ, Brash AR, Dubois RN: 15S-hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells. Cancer Res 2001;61:497-503.
29. 2 and EETs in the relaxation of bovine coronary arteries to arachidonic acid. Am J Physiol 1993;264:H327-H335.
30. Pfister SL, Spitzbarth N, Nithipatikom K, Edgemond WS, Falck JR, Campbell WB: Identification of 11,14,15- and 11,12,15-trihydroxyeicosatrienoic acids as endothelium-derived relaxing factors of rabbit aorta. J Biol Chem 1998;273:30879-30887.
31. Vistica DT, Skehan P, Scudiero D, Monks A, Pittman A, Boyd MR: Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res 1991;51:2515-2520.
32. Hsu SM, Raine L, Fanger H: A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 1981;75:734-738.
33. Lynch MA, Nakashima R, Song H, DeGroff V, Wang D, Enomoto T, Weghorst CM: Mutational analysis of the transforming growth factor beta receptor type II gene in human ovarian carcinoma. Cancer Res 1998;58:4227-4232.
34. Kitty I, Logan A, Vickers PJ: Differential characteristics of human 15-lipoxygenase isoenzymes and a novel splice variant of 15S-lipoxygenase. Eur J Biochem 1999;266:83-93.
35. Smith WL, Garavito RM, DeWitt DL: Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996;271:33157-33160.
36. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN: Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 1987;237:1171-1176.
37. Lewis RA, Austen KF, Soberman RJ: Leukotrienes and other products of the 5-lipoxygenase pathway. Mech Dis 1990;322:645-655.
38. Funk CD: The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice. Biochim Biophys Acta 1996;1304:65-84.
39. Minter HA, Eveson JW, Huntley S, Elder DJ, Hague A: The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 sysnthesis. Clin Cancer Res 2003;9:1885-1897.
40. Chan G, Boyle JO, Yang EK, Zhang F, Sacks PG, Shah JP, Edelstein D, Soslow RA, Koki AT, Woerner BM, Masferrer JL, Dannenberg AJ: Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 1999;59:991-994.
41. Jung TT, Berlinger NT, Juhn SK: Prostaglandins in squamous cell carcinoma of the head and neck: a preliminary study. Laryngoscope 1985;95:307-312.
42. Mestre JR, Chan G, Zhang F, Yang EK, Sacks PG, Boyle JO, Shah JP, Edelstein D, Subbaramaiah K, Dannenberg AJ: Inhibition of cyclooxygenase-2 expression: an approach to preventing head and neck cancer. Ann NY Acad Sci 1999;889:62-71.